Completed NA INTERVENTIONAL 2-arm NCT01764230

Prevention of Ovarian Function Damage by a GnRH Analogue During Chemotherapy in Hodgkin Lymphoma Patients (OVARONKO)

Sponsor: Masaryk University

Conditions Hodgkin Disease Hodgkin Lymphoma

Interventions triptorelin

Updated 6 times since 2017 Last updated: Jan 7, 2013 Started: Jan 31, 2004 Primary completion: Jul 31, 2007 Completion: Jan 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01764230, this NA trial focuses on Hodgkin Disease and Hodgkin Lymphoma and remains completed. Sponsored by Masaryk University, it has been updated 6 times since 2004, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Jan 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Masaryk University
Ministry of Health, Czech Republic

Data source: Masaryk University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Brno, Czechia